Opus Genetics (IRD) Share-based Compensation Growth (3y) (2013 - 2026)
Opus Genetics (IRD) Share-based Compensation Growth (3y) (2013 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
Stock Comp. Growth (3y) (Qtr) |
| 1 |
Alterity Therapeutics |
925,601.88 Bn |
925,601.85 Bn |
- |
- |
| 2 |
Belite Bio |
58,560.00 Bn |
58,560.00 Bn |
- |
- |
| 3 |
Quantum Biopharma |
17,284.41 Bn |
17,284.40 Bn |
- |
- |
| 4 |
Legend Biotech |
2,809.00 Bn |
2,808.71 Bn |
242.10 Mn |
- |
| 5 |
Evaxion A |
1,334.43 Bn |
1,334.42 Bn |
- |
- |
| 6 |
Akari Therapeutics |
1,312.27 Bn |
1,312.26 Bn |
- |
4.80% |
| 7 |
Psyence Biomedical |
212.16 Bn |
212.16 Bn |
- |
- |
| 8 |
Vertex Pharmaceuticals |
114.83 Bn |
107.58 Bn |
2.59 Bn |
10.78% |
| 9 |
Abivax |
91.96 Bn |
91.96 Bn |
- |
- |
| 10 |
Opus Genetics |
355.39 Mn |
295.43 Mn |
- |
-81.90% |
| Date | Value |
|---|
| Mar 31, 2026 |
-81.90% |
| Dec 31, 2025 |
-27.13% |
| Sep 30, 2025 |
102.00% |
| Jun 30, 2025 |
26.27% |
| Mar 31, 2025 |
27.07% |
| Dec 31, 2024 |
87.59% |
| Jun 30, 2024 |
202.91% |
| Mar 31, 2024 |
-20.84% |
| Dec 31, 2023 |
11.49% |
| Sep 30, 2023 |
-2.38% |
| Jun 30, 2023 |
65.10% |
| Mar 31, 2023 |
1,493.88% |
| Dec 31, 2022 |
-158.26% |
| Sep 30, 2022 |
2.96% |
| Jun 30, 2022 |
51.63% |
| Mar 31, 2022 |
40.34% |
| Dec 31, 2021 |
37.19% |
| Sep 30, 2021 |
-54.80% |
| Jun 30, 2021 |
-52.30% |
| Mar 31, 2021 |
18.54% |
